SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Abroad (travel likely)RecruitingPHASE3
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Glioma · Astrocytoma, Grade IV · IDH1-mutant Glioma · Astrocytoma, IDH-Mutant, Grade 3 · Astrocytoma, IDH-Mutant, Grade 4 · Astrocytoma, IDH-Mutant, Grade 2 · Oligodendroglioma · Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted
Locations
- University of Alabama, Birmingham, Alabama, United States
- Mayo Clinic - Arizona, Phoenix, Arizona, United States
- St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
- University of California, Los Angeles, Los Angeles, California, United States
- Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
- Stanford University, Palo Alto, California, United States
- University of California, San Francisco, California, United States
- University of Colorado Health Cancer Care, Aurora, Colorado, United States
- Yale University, New Haven, Connecticut, United States
- University of Florida Health, Gainesville, Florida, United States
- Mayo Clinic - Florida, Jacksonville, Florida, United States
- University of Miami Health, Miami, Florida, United States
- Orlando Health Cancer Institute, Orlando, Florida, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Dana-Farber Cancer Institute, Boston, Massachusetts, United States
- Henry Ford Hospital, Detroit, Michigan, United States
- Mayo Clinic - Rochester, Rochester, Minnesota, United States
- Washington University, St Louis, Missouri, United States
- Rutgers Cancer Institute, New Brunswick, New Jersey, United States
- NYU Langone Health, New York, New York, United States
- Columbia University Medical Center, New York, New York, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Duke Cancer Institute, Durham, North Carolina, United States
- Cleveland Clinic, Cleveland, Ohio, United States
- University of Texas Southwestern Medical Center, Dallas, Texas, United States
- MD Anderson Cancer Center, Houston, Texas, United States
- Huntsman Cancer Insititute, University of Utah, Salt Lake City, Utah, United States
- UVA Health, Emily Couric Clinical Cancer Cente, Charlottesville, Virginia, United States
- Fred Hutch Cancer Center, Seattle, Washington, United States
- University of Wisconsin Health, Madison, Wisconsin, United States
- St Vincents Hospital Sydney (Kinghorn), Darlinghurst, New South Wales, Australia
- Royal North Shore Hospital, Saint Leonards, New South Wales, Australia
- Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
- Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
- The Alfred, Melbourne, Victoria, Australia
- Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing Municipality, China
- Sanbo Brain Hospital, Capital Medical University, Beijing, Beijing Municipality, China
- Xuanwu Hospital, Capital Medical University, Beijing, Beijing Municipality, China
- Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
- The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
- Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
- Xiangya Hospital of Central South University, Changsha, Hunan, China
- Huashan Hospital Affiliated to Fudan University, Shanghai, Shanghai Municipality, China
- West China Hospital of Sichuan University, Chengdu, Sichuan, China